These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27497268)

  • 1. Integrated molecular and bioprocess engineering for bacterially produced immunogenic modular virus-like particle vaccine displaying 18 kDa rotavirus antigen.
    Tekewe A; Fan Y; Tan E; Middelberg AP; Lua LH
    Biotechnol Bioeng; 2017 Feb; 114(2):397-406. PubMed ID: 27497268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design strategies to address the effect of hydrophobic epitope on stability and in vitro assembly of modular virus-like particle.
    Tekewe A; Connors NK; Middelberg AP; Lua LH
    Protein Sci; 2016 Aug; 25(8):1507-16. PubMed ID: 27222486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic biology design to display an 18 kDa rotavirus large antigen on a modular virus-like particle.
    Lua LH; Fan Y; Chang C; Connors NK; Middelberg AP
    Vaccine; 2015 Nov; 33(44):5937-44. PubMed ID: 26387437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana.
    Pêra FF; Mutepfa DL; Khan AM; Els JH; Mbewana S; van Dijk AA; Rybicki EP; Hitzeroth II
    Virol J; 2015 Dec; 12():205. PubMed ID: 26626122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles.
    Li T; Lin H; Zhang Y; Li M; Wang D; Che Y; Zhu Y; Li S; Zhang J; Ge S; Zhao Q; Xia N
    Vaccine; 2014 Apr; 32(17):1921-31. PubMed ID: 24530406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination.
    Waneesorn J; Wibowo N; Bingham J; Middelberg APJ; Lua LHL
    Vaccine; 2018 May; 36(22):3064-3071. PubMed ID: 27894719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8
    Pattinson DJ; Apte SH; Wibowo N; Rivera-Hernandez T; Groves PL; Middelberg APJ; Doolan DL
    Front Immunol; 2020; 11():564627. PubMed ID: 33133076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
    Malm M; Heinimäki S; Vesikari T; Blazevic V
    Clin Exp Immunol; 2017 Sep; 189(3):331-341. PubMed ID: 28407442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines.
    Middelberg AP; Rivera-Hernandez T; Wibowo N; Lua LH; Fan Y; Magor G; Chang C; Chuan YP; Good MF; Batzloff MR
    Vaccine; 2011 Sep; 29(41):7154-62. PubMed ID: 21651936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
    Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
    BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial production of virus-like particle vaccine protein at gram-per-litre levels.
    Liew MW; Rajendran A; Middelberg AP
    J Biotechnol; 2010 Oct; 150(2):224-31. PubMed ID: 20797415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.
    Chuan YP; Wibowo N; Connors NK; Wu Y; Hughes FK; Batzloff MR; Lua LH; Middelberg AP
    Biotechnol Bioeng; 2014 Jun; 111(6):1062-70. PubMed ID: 24338691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
    Wu PC; Chen TY; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput process development of an alternative platform for the production of virus-like particles in Escherichia coli.
    Ladd Effio C; Baumann P; Weigel C; Vormittag P; Middelberg A; Hubbuch J
    J Biotechnol; 2016 Feb; 219():7-19. PubMed ID: 26707548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
    Gil MT; de Souza CO; Asensi M; Buesa J
    Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine.
    Chuan YP; Rivera-Hernandez T; Wibowo N; Connors NK; Wu Y; Hughes FK; Lua LH; Middelberg AP
    Biotechnol Bioeng; 2013 Sep; 110(9):2343-51. PubMed ID: 23532896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
    Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.